We are live on
!
Find out more
CCM
Camber Capital Management Portfolio holdings
AUM
$1.07B
1-Year Est. Return
8.19%
This Fund
S&P 500
This Quarter
Est. Return
+9.46%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$2.97B
AUM Growth
+$53.8M
(+1.8%)
Cap. Flow
-$158M
Cap. Flow
% of AUM
-5.32%
Top 10 Holdings %
Top 10 Hldgs %
47.74%
Holding
40
New
8
Increased
11
Reduced
7
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sanofi
SNY
|
+$117M |
| 2 |
Cardinal Health
CAH
|
+$73M |
| 3 |
SkinHealth Systems
SKIN
|
+$54.7M |
| 4 |
HOLX
Hologic
HOLX
|
+$44.5M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$44.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$205M |
| 2 |
Zimmer Biomet
ZBH
|
+$100M |
| 3 |
Universal Health Services
UHS
|
+$94.5M |
| 4 |
Welltower
WELL
|
+$58M |
| 5 |
Ventas
VTR
|
+$48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 81.68% |
| 2 | Miscellaneous | 14.24% |
| 3 | Consumer Staples | 2.26% |
| 4 | Technology | 1.82% |
| 5 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHNG
26
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $54.1M | 1.82% |
2,350,000
-8,900,000
| -79% | -$205M |
|
27
Collegium Pharmaceutical
COLL
$739M
| $47.3M | 1.59% |
2,000,000
| – | – |
|
|
HOLX
28
DELISTED
Hologic
HOLX
| $44.4M | 1.49% |
+665,000
| New | +$44.5M |
|
|
TBIO
29
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $38.6M | 1.3% |
1,400,000
+250,000
| +22% | +$4.91M |
|
30
OraSure Technologies
OSUR
$243M
| $36.3M | 1.22% |
3,575,000
| – | – |
|
|
TECX
31
Tectonic Therapeutic
TECX
$557M
| $27.9M | 0.94% |
261,111
| – | – |
|
|
RDUS
32
DELISTED
Radius Health, Inc.
RDUS
| $27.4M | 0.92% |
1,500,000
| – | – |
|
33
InnovAge Holding
INNV
$1.48B
| $26.7M | 0.9% |
1,253,000
+603,000
| +93% | +$13.8M |
|
34
Puma Biotechnology
PBYI
$479M
| $25M | 0.84% |
2,725,000
+170,000
| +7% | +$1.72M |
|
|
BLUE
35
DELISTED
bluebird bio
BLUE
| – | – |
-77,200
| Closed | -$30.1M |
|
36
Incyte
INCY
$25.3B
| – | – |
-500,000
| Closed | -$40.6M |
|
37
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$801B
| – | – |
-1,000,000
| Closed | -$396M |
|
|
38
Ventas
VTR
$45.3B
| – | – |
-900,000
| Closed | -$48M |
|
|
39
Welltower
WELL
$169B
| – | – |
-810,000
| Closed | -$58M |
|
|
40
Zimmer Biomet
ZBH
$18.7B
| – | – |
-643,750
| Closed | -$100M |
|
Similar funds
PP
SAF
NRD
FC
GIM
SC
BWA
CCP
Camber Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Camber Capital Management held 40 positions worth $2.97B, up 1.8% from $2.91B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Camber Capital Management withdrew a net $158M in Q2 2021, closing 6 positions and reducing 7 holdings. Its most notable exit was Zimmer Biomet, an estimated $100M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 74% a quarter earlier, followed by Miscellaneous and Consumer Staples.
Against the trend, Camber Capital Management opened a new position in Sanofi worth $118M.
- Camber Capital Management's largest Q2 2021 buy was Sanofi: 2,250,000 shares worth $118M.
- Camber Capital Management added most to Mirati Therapeutics, Inc. Common Stock in Q2 2021, an estimated $44.2M increase.
- Camber Capital Management's biggest Q2 2021 reduction was Change Healthcare Inc. Common Stock, cutting an estimated $205M.
- Camber Capital Management fully exited Zimmer Biomet in Q2 2021, selling an estimated $100M.
- Camber Capital Management's ten largest holdings make up 48% of its $2.97B portfolio in Q2 2021.
- Camber Capital Management opened 8 new positions and closed 6 in Q2 2021.
- Camber Capital Management's portfolio value rose 1.8% quarter-over-quarter to $2.97B.
Based on Camber Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.